Simultaneous Gemcitabine and Irreversible Electroporation for Locally Advanced Pancreatic Cancer

Clinical trial NCT02981719 · COMPLETED

Trial details

NCT number: NCT02981719
Sponsor: Fuda Cancer Hospital, Guangzhou
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Pancreatic Cancer

Start date: 2016-10-01
Primary completion: 2018-10-01
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.